XML 55 R44.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaborative and Other Agreements (Narrative) (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2016
Sep. 30, 2015
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Licensing Payments Received $ 103,000   $ 102,000 $ 209,000 $ 204,000  
Intrexon Corporation [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Fees Payable Upon Commencement Of The First Phase 2 Trial 2,500,000     2,500,000    
Fees Payable Upon First Regulatory Approval 5,000,000     5,000,000    
Expenses Incurred Under Channel Collaborative Agreement 22,000   22,000 76,000 44,000  
Cash Paid For Channel Collaboration Agreement 60,000   31,000 117,000 35,000  
Liability for amounts due to terminated channel collaboration partner 15,000     15,000    
University Of Leicester [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Expenses Incurred Under Channel Collaborative Agreement 43,000   53,000 86,000 88,000  
Cash Paid For Channel Collaboration Agreement 94,000   115,000 140,000 165,000  
University Of Glasgow [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Expenses Incurred Under Channel Collaborative Agreement 0   0 0 13,000  
Cash Paid For Channel Collaboration Agreement 0   0 0 61,000  
Walter Reed Army Institute Of Research [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Payments For Services Under Collaborative Agreement 0   $ 0 0 $ 0  
Takara Bio Inc [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Licensing Payments Received   $ 40,000        
Patent license agreement revenue $ 4,000     $ 8,000    
Takara Bio Inc [Member] | Nonsoftware License Arrangement [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Percent of License Product Sales Receivable 12.00%          
Percent of License Product Service Revenues Receivable 6.00%          
Minimum Annual Royalty Payments Receivable $ 15,000          
Takara Bio Inc [Member] | Nonsoftware License Arrangement [Member] | Criteria One [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Contingent Licensing Receivable 30,000          
Licensed Product Revenues Milestone Benchmark 1,000,000          
Takara Bio Inc [Member] | Nonsoftware License Arrangement [Member] | Criteria Two [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Contingent Licensing Receivable 40,000          
Licensed Product Net Sales Milestone Benchmark $ 2,000,000          
Common Stock [Member] | Intrexon Corporation [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Stock Issued During Period, Value, Issued for Services           $ 3,000,000